-+ 0.00%
-+ 0.00%
-+ 0.00%

ALNYLAM PHARMACEUTICALS - PLACEBO-CONTROLLED PIVOTAL STUDY PLANNED FOR 2027 PENDING REGULATORY ALIGNMENT

Reuters·10/23/2026 07:45:00

Please log in to view news